The Role of Maternal Breast Milk in Preventing Infantile Diarrhea in the Developing World

Current Tropical Medicine Reports

Volumn 1, Issue 2, 2014, Pages 97-105

  Turin, Christie G ^a   Ochoa, Theresa J ^a,b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibodies; Bacterial tropical medicine; Breast milk; Breastfeeding; Children; Developing countries; Diarrhea; Enteric pathogens; Gastroenteritis; GI infections; Human milk; Infants; Lactoferrin; Morbidity; Mortality; Nutrition; Oligosaccharides; Protective factors; Tropical medicine

Indexed keywords

ALPHA LACTALBUMIN; GANGLIOSIDE GM1; GANGLIOSIDE GM3; HYALURONIC ACID; IMMUNOGLOBULIN G; KAPPA CASEIN; LACTADHERIN; LACTOFERRIN; LACTOPEROXIDASE; LYSOZYME; MUCIN; OLIGOSACCHARIDE; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN;

ANTIMICROBIAL ACTIVITY; BIFIDOBACTERIUM; BREAST FEEDING; BREAST FEEDING EDUCATION; BREAST MILK; DEVELOPING COUNTRY; FOOD COMPOSITION; HUMAN; IMMUNITY; INFANTILE DIARRHEA; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84919706503     PISSN: None     EISSN: 21963045     Source Type: Journal    
DOI: 10.1007/s40475-014-0015-x     Document Type: Review

References (61)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–61. The Child Health Epidemiology Reference Group (CHERG) of WHO and UNICEF has systematically estimated the distribution of child mortality by cause at the regional and global level for year 2010. Neonatal complications, pneumonia and diarrhea are the leading causes of death worldwide.
2. Bhutta ZA, Black RE. Global maternal, newborn, and child health–so near and yet so far. N Engl J Med. 2013;369:2226–35.
3. Guerrant RL, Oriá RB, Moore SR, et al. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev. 2008;66:487–505.
4. Walker CLF, Friberg IK, Binkin N, et al. Scaling up diarrhea prevention and treatment interventions: a lives saved tool analysis. PLoS Med. 2011;8:e1000428.
5. Bhutta ZA, Das JK, Walker N, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381:1417–29. Systematic review of studies showing the effectiveness of various interventions (preventive and therapeutic) against childhood diarrhea and pneumonia, and relevant delivery strategies. Breastfeeding is one of the most cost-effective interventions to lessen diarrhea burden.
6. Jones G, Steketee RW, Black RE, et al. How many child deaths can we prevent this year? Lancet. 2003;362:65–71.
7. Morrow AL, Rangel JM. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis. 2004;15:221–8.
8. Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health. 2011;11:S15. A systematic review of 18 clinical studies found a significant positive effect of breastfeeding against diarrhea incidence, prevalence, hospitalization and mortality. The degree of protection is depended on the level of breastfeeding exposure. This supports current WHO recommendation for exclusive breastfeeding during the first 6 months of life as a key child survival intervention.
9. Arifeen S, Black RE, Antelman G, et al. Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics. 2001;108:E67.
10. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60. This study evaluated the leading risk factors that increase mortality and disability worldwide. Suboptimal breastfeeding showed a significant negative effect on children health, which was measure by deaths and disability-adjusted life years.
11. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382:427–51. Systematic evaluation of the nutritional status and factors associated with undernutrition of mothers and children from low and middle income countries. Suboptimal breastfeeding increased the risk of death in children younger than 2 years of age.
12. Roberts TJ, Carnahan E, Gakidou E. Can breastfeeding promote child health equity? A comprehensive analysis of breastfeeding patterns across the developing world and what we can learn from them. BMC Med. 2013;11:254. Analysis of breastfeeding practices in 137 developing countries from 1990 to 2010. Researchers found a wide range of breastfeeding prevalence and an increase in disability-adjusted life years secondary to suboptimal breastfeeding.
13. World Health Organization. The optimal duration of exclusive breastfeeding: report of an expert consultation. Geneva: World Health Organization; 2001.
14. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012, 129:e827-841.
15. Haroon S, Das JK, Salam RA, et al. Breastfeeding promotion interventions and breastfeeding practices: a systematic review. BMC Public Health. 2013;13:1–18. Systematic review of 110 randomized studies on the effectiveness of various intervention and delivery strategies to increase rates of exclusive breastfeeding.
16. Imdad A, Yakoob MY, Bhutta ZA. Effect of breastfeeding promotion interventions on breastfeeding rates, with special focus on developing countries. BMC Public Health. 2011;11:S24.
17. Lawrence RM. Circumstances when breastfeeding is contraindicated. Pediatr Clin North Am. 2013;60:295–318.
18. Bosch AM, Grootenhuis MA, Bakker HD, et al. Living with classical galactosemia: health-related quality of life consequences. Pediatrics. 2004;113:e423–8.
19. Horvath T, Madi BC, Iuppa IM, et al. Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev. 2009;1, CD006734.
20. Gonçalves DU, Proietti FA, Ribas JGR, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23:577–89.
21. Ballard O, Morrow AL. Human Milk Composition. Pediatr Clin North Am. 2013;60:49–74. Very comprehensive review of the nutrients and bioactive factors present in human milk; the factors associated with the variability on human milk composition, and the impact of storage and pasteurization on milk components.
22. Smilowitz JT, O’Sullivan A, Barile D, et al. The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013;143:1709–18.
23. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22:1147–462. Comprehensive review on human milk oligosaccharides structure, composition, variation, biosynthesis, and postulated beneficial effects for the breastfed neonate: antiadhesive antimicrobial, immune modulation, NEC protection, brain development among others.
24. Morrow AL, Ruiz-Palacios GM, Jiang X, et al. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005;135:1304–7.
25. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005;25:37–58.
26. Zivkovic AM, German JB, Lebrilla CB, et al. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci. 2011;108:4653–8.
27. Ruiz-Palacios GM, Cervantes LE, Ramos P, et al. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 2003;278:14112–20.
28. Morrow AL, Ruiz-Palacios GM, Altaye M, et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr. 2004;145:297–303.
29. Coppa GV, Zampini L, Galeazzi T, et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 2006;59:377–82.
30. Cano-Mancera R, López-Revilla R. Inhibition of the adhesion of Entamoeba histolytica trophozoites to human erythrocytes by carbohydrates. Parasitol Res. 1987;74:18–22.
31. Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr. 2010;156:S8–15.
32. Peterson R, Cheah WY, Grinyer J, et al. Glycoconjugates in human milk: Protecting infants from disease. Glycobiology. 2013;23:1425–38. Comprehensive review of the variety of human milk glycoconjugates, their function and the mechanism for preventing children’s diseases.
33. Durand D, Ochoa TJ, Bellomo SME, et al. Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli. Pediatr Infect Dis J. 2013;32:1122–6.
34. Korpe PS, Liu Y, Siddique A, et al. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin Infect Dis. 2013;56:988–92.
35. Berlutti F, Pantanella F, Natalizi T, et al. Antiviral properties of lactoferrin–a natural immunity molecule. Mol Basel Switz. 2011;16:6992–7018.
36. Vogel HJ. Lactoferrin, a bird’s eye view. Biochem Cell Biol. 2012;90:233–44. Review of lactoferrin structure and beneficial functional properties: antimicrobial, anti-cancer, immunoregulatory, and other effects on human health.
37. Brock JH. Lactoferrin–50 years on. Biochem Cell Biol. 2012;90:245–51.
38. Baker HM, Baker EN. A structural perspective on lactoferrin function. Biochem Cell Biol. 2012;90:320–8.
39. Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. Biochimie. 2009;91:30–4.
40. Gomez HF, Ochoa TJ, Herrera-Insua I, et al. Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun. 2002;70:7050–3.
41. Mosquito S, Ochoa TJ, Cok J, et al. Effect of bovine lactoferrin in Salmonella ser. Typhimurium infection in mice. Biometals. 2010;23:515–21.
42. Rivera FP, Medina AM, Bezada S, et al. Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction. PloS One. 2013;8:e59253.
43. Lingappan K, Arunachalam A, Pammi M. Lactoferrin and the newborn: current perspectives. Expert Rev Anti Infect Ther. 2013;11:695–707.
44. Ochoa TJ, Pezo A, Cruz K, et al. Clinical studies of lactoferrin in children. Biochem Cell Biol. 2012;90:457–67. Review of 19 clinical studies evaluating the effect human or bovine lactoferrin on various health outcomes in children. Three studies focused on prevention and treatment of enteric infections and possible mechanisms of protection.
45. Egashira M, Takayanagi T, Moriuchi M, et al. Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis? Acta Paediatr. 2007;96:1242–4.
46. Zavaleta N, Figueroa D, Rivera J, et al. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr. 2007;44:258–64.
47. Ochoa TJ, Chea-Woo E, Campos M, et al. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin Infect Dis. 2008;46:1881–3.
48. Ochoa TJ, Chea-Woo E, Baiocchi N, et al. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr. 2013;162:349–56. Randomized trial of bovine lactoferrin supplementation in children with intense diarrhea surveillance. There was no effect on diarrhea incidence; however, there was a significant decrease in diarrhea longitudinal prevalence and severity, although not clinically significant at the dose studied.
49. Hill DR, Rho HK, Kessler SP, et al. Human milk hyaluronan enhances innate defense of the intestinal epithelium. J Biol Chem. 2013;288(40):29090–104.
50. Liu B, Yu Z, Chen C, et al. Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro. J Nutr. 2012;142:1504–9.
51. Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet. 1998;351:1160–4.
52. Asensi MT, Martínez-Costa C, Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatr Gastroenterol Nutr. 2006;42:560–7.
53. Fernandez L, Langa S, Martin V, Maldonado A, Jimenez E, Martin R, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res Off J Ital Pharmacol Soc. 2013;69:1–10.
54. Latuga MS, Stuebe A, Seed PC. A review of the source and function of microbiota in breast milk. Semin Reprod Med. 2014;32:68–73.
55. Hunt KM, Foster JA, Forney LJ, et al. Characterization of the Diversity and Temporal Stability of Bacterial Communities in Human Milk. PLoS One. 2011;6:e21313.
56. Martín R, Heilig GHJ, Zoetendal EG, et al. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol. 2007;103:2638–44.
57. Martin R, Jimenez E, Heilig H, et al. Isolation of Bifidobacteria from Breast Milk and Assessment of the Bifidobacterial Population by PCR-Denaturing Gradient Gel Electrophoresis and Quantitative Real-Time PCR. Appl Environ Microbiol. 2009;75:965–9.
58. Kawano A, Emori Y. Changes in maternal secretory immunoglobulin a levels in human milk during 12 weeks after parturition. Am J Hum Biol. 2013;25:399–403.
59. Gabrielli O, Zampini L, Galeazzi T, et al. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128:e1520–31.
60. Cabrera-Rubio R, Collado MC, Laitinen K, et al. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012;96:544–51.
61. World Health Organization. Global strategy on infant and young child feeding. Geneva: World Health Organization; 2003.